Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity.

about

Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.

P2860

Q41812639-8C7371FC-CE93-4480-BB41-236D0C909A55

P2860

Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity.

Item

http://www.wikidata.org/entity/Q36883778

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Synthesis of novel estrogen re ...... of their biological activity.

@en

type

Item

label

Synthesis of novel estrogen re ...... of their biological activity.

@en

prefLabel

Synthesis of novel estrogen re ...... of their biological activity.

@en

P1476

Synthesis of novel estrogen re ...... of their biological activity.

@en

P2093

Bao Ting Zhu

http://www.w3.org/2001/XMLSchema#string

Carolyn L Smith

http://www.w3.org/2001/XMLSchema#string

Pan Wang

http://www.w3.org/2001/XMLSchema#string

Xiang-Rong Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Structural insights into the mode of action of a pure antiestrogen

Molecular basis of agonism and antagonism in the oestrogen receptor

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Role of CBP/P300 in nuclear receptor signalling

Parallel solid-phase synthesis of a model library of 7alpha-alkylamide estradiol derivatives as potential estrogen receptor antagonists.

A fluorogenic 1,3-dipolar cycloaddition reaction of 3-azidocoumarins and acetylenes.

Characterization of the oestrogenic activity of non-aromatic steroids: are there male-specific endogenous oestrogen receptor modulators?

Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms.

Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions.

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.

P304

2779-2790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JM3013773

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23448346

http://www.w3.org/2001/XMLSchema#string

P932

3666588

http://www.w3.org/2001/XMLSchema#string

Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity.

about

P2860

P2860

Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932